Cite
[A Case of Cholangiocellular Carcinoma in Lynch Syndrome Treated by an Immune Checkpoint Inhibitor].
MLA
Shinke, Go, et al. “[A Case of Cholangiocellular Carcinoma in Lynch Syndrome Treated by an Immune Checkpoint Inhibitor].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 48, no. 13, Dec. 2021, pp. 2014–16. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=35045478&authtype=sso&custid=ns315887.
APA
Shinke, G., Takeda, Y., Ohmura, Y., Katsura, Y., Haruna, K., Kihara, Y., Kusafuka, H., Sakaue, M., Katsuyama, S., Kawai, K., Hiraki, M., Masuzawa, T., Takeno, A., Hata, T., & Murata, K. (2021). [A Case of Cholangiocellular Carcinoma in Lynch Syndrome Treated by an Immune Checkpoint Inhibitor]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 48(13), 2014–2016.
Chicago
Shinke, Go, Yutaka Takeda, Yoshiaki Ohmura, Yoshiteru Katsura, Kengo Haruna, Yukari Kihara, Hiroshi Kusafuka, et al. 2021. “[A Case of Cholangiocellular Carcinoma in Lynch Syndrome Treated by an Immune Checkpoint Inhibitor].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 48 (13): 2014–16. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=35045478&authtype=sso&custid=ns315887.